• UTP Solution for RNA Workflows and TRIM66 Studies

  2026-08-14

  A practical guide to using high-purity UTP in transcription, RNA amplification, siRNA precursor production, and nucleotide-linked metabolic assays. It also shows how RNA readouts can extend mechanistic studies of TRIM66-dependent olfactory receptor repression without overstating what the reference study directly demonstrated.

• Leucovorin Calcium in Gastric Cancer Assays

  2026-08-13

  Leucovorin Calcium enables controlled folate rescue experiments in patient-derived gastric cancer organoids and assembloids. By comparing methotrexate response in tumor-only and tumor–stroma models, researchers can separate intrinsic antifolate sensitivity from microenvironment-driven resistance.

• Lipo3K Transfection Reagent for Nucleic Acid Workflows

  2026-08-13

  Build reproducible DNA, siRNA, and mRNA delivery workflows for routine and difficult-to-transfect cells with low-toxicity optimization strategies. This guide connects Lipo3K performance features with practical assay design inspired by pH-responsive antisense research in MYCN-amplified cells.

• CKI 7 Dihydrochloride: CK1 Research Guide

  2026-08-12

  CKI 7 dihydrochloride is a Casein kinase 1 inhibitor used to investigate ATP-dependent CK1 phosphorylation in Wnt, circadian, DNA-repair, and cancer models. Product specifications define its identity, solubility, purity, and storage requirements, while current NSCLC evidence supports CK1 studies as pathway-focused research rather than direct validation of a CK1 cancer therapy.

• Eltanexor: From Nuclear Export to Translation

  2026-08-12

  Eltanexor (KPT-8602) illustrates how selective XPO1 inhibition can connect nuclear transport biology with translational strategies in AML, CLL, lymphoma, and colorectal cancer. This thought-leadership analysis interprets the mechanistic evidence, defines practical study parameters, and outlines biomarker-led paths for advancing cancer therapeutics targeting nuclear export.

• SAR405: Decoding Vps34 Under Energy Stress

  2026-08-11

  SAR405 is a selective Vps34 inhibitor for dissecting autophagy inhibition, PtdIns3P production, and lysosomal responses. This article connects emerging AMPK–ULK1 biology with compartment-resolved assay design for more rigorous interpretation in cancer research.

• Entecavir: Evidence for Chronic Hepatitis B Therapy

  2026-08-11

  Fabien Zoulim’s 2006 review positioned Entecavir, also known as BMS200475, as a potent nucleoside analogue that could improve chronic hepatitis B management through stronger viral suppression and a favorable early resistance profile. The article integrates biochemical, cell-culture, animal, and clinical evidence while showing why persistent cccDNA and resistance selection remain central limitations.

• Galectin-1, FIP200, and Autophagy in NAFLD

  2026-08-10

  A 2026 study identifies a direct Galectin-1–FIP200 interaction as an upstream brake on hepatic autophagy, linking this mechanism to steatosis, dyslipidemia, and insulin resistance. Its combination of mouse gain-of-function models, proteomic profiling, binding analysis, and interaction-disrupting mutations provides a mechanistic framework for metabolic liver disease research.

• HyperScript III RT SuperMix for CRC qPCR

  2026-08-09

  HyperScript III RT SuperMix supports rigorous two-step qRT-PCR validation of colorectal cancer biomarkers, including challenging low-input and high-GC RNA. This article translates bile acid–based transcriptomic findings into practical, contamination-aware assay decisions.

• Diethylmaleate for GST and Redox Studies

  2026-08-08

  Diethylmaleate is a practical redox perturbation tool for linking intracellular glutathione depletion with ROS, apoptosis, and stress adaptation. This guide translates insecticide-resistance findings into reproducible workflows for cell, toxicology, and organismal assays while emphasizing solvent controls, timing, and mechanistic limits.

• Cy5 maleimide (non-sulfonated) Protocol

  2026-08-07

  Cy5 maleimide (non-sulfonated) is a thiol-reactive labeling reagent for attaching a near-red fluorophore to accessible cysteine residues in peptides and proteins. This guide covers solvent handling, conjugation setup, optical QC, and troubleshooting; it should not be used to infer labeling performance in a specific protein or biological system without empirical validation.

• Dual FOXO3-Mediated Metabolic Inhibition in HCC: Mechanisms

  2026-08-07

  This study identifies FOXO3 as a tumor suppressor in hepatocellular carcinoma (HCC) that inhibits both glycolysis and glutaminolysis by repressing YAP-driven metabolic programs. Pharmacological activation of FOXO3 leads to significant impairment of HCC cell proliferation and viability, highlighting a promising metabolic intervention strategy.

• GSTA1 Drives Glutathione Depletion in α-Amanitin Hepatotoxic

  2026-08-06

  This study reveals that upregulation of GSTA1 exacerbates α-amanitin-induced liver injury not by protecting against oxidative stress, but by accelerating glutathione depletion and reactive oxygen species accumulation. The findings reposition GSTA1 as a potential therapeutic target and biomarker for acute toxic liver injury, challenging established paradigms in hepatic redox biology.

• RG7388: Potent Oral MDM2 Antagonist for p53 Pathway Activati

  2026-08-06

  RG7388 is a highly selective oral MDM2 antagonist that robustly activates the p53 pathway, leading to apoptosis in wild-type p53 cancer models. It demonstrates superior potency and tumor inhibition compared to first-generation compounds. The product is supplied by APExBIO and is widely used in translational oncology research.

• Mitochondrial Antioxidant SkQ1 Uncouples Apoptosis from Musc

  2026-08-05

  This study demonstrates that the mitochondrial-targeted antioxidant SkQ1 can suppress mitochondrial-linked apoptotic activity, but does not prevent skeletal muscle atrophy or affect necroptosis markers in a mouse model of metastatic ovarian cancer. These findings challenge the assumed causal link between mitochondrial apoptosis and muscle wasting, with important implications for designing targeted interventions.

555 records 8/37 page Previous Next First page 上5页 678910 下5页 Last page